文献速递基础与转化研究新药、器械与细胞基因治疗研发

溶瘤病毒递送CAR靶点实现实体瘤联合免疫治疗

Effective combination immunotherapy using oncolytic viruses to deliver CAR targets to solid tumors.
PubMed 文献 · Sci Transl Med · 2020-01-01

该研究改造溶瘤牛痘病毒表达非信号型截短CD19(CD19t),使肿瘤细胞表面从头表达CD19,从而被CD19-CAR T细胞靶向。体外实验显示CD19-CAR T细胞对感染肿瘤细胞分泌细胞因子并发挥强效杀伤。多种小鼠肿瘤模型中,OV19t递送联合CD19-CAR T细胞给药促进肿瘤控制,并诱导内源性和过继转移T细胞浸润肿瘤。

要点

  • 溶瘤病毒OV19t使肿瘤细胞表面从头表达CD19t,为CAR T细胞提供可靶向抗原。
  • CD19-CAR T细胞对OV19t感染肿瘤细胞有强效细胞因子分泌和杀伤活性。
  • 小鼠模型中OV19t联合CD19-CAR T细胞促进肿瘤控制并诱导T细胞浸润。

核心结论

  • 溶瘤病毒递送CD19t可使实体瘤从头表达CAR靶点,联合CD19-CAR T细胞实现肿瘤控制。

研究设计与样本

  • 工程化溶瘤牛痘病毒表达非信号型截短CD19(CD19t),体外共培养评估CD19-CAR T细胞反应。
  • 使用多种小鼠肿瘤模型评估OV19t递送后CD19-CAR T细胞给药的抗肿瘤效果。

主要发现

  • OV19t感染肿瘤细胞后在病毒介导的肿瘤裂解前于细胞表面产生从头CD19。
  • 共培养的CD19-CAR T细胞分泌细胞因子并对感染肿瘤表现出强效细胞溶解活性。
  • 多种小鼠肿瘤模型中,OV19t递送促进CD19-CAR T细胞给药后的肿瘤控制。
  • OV19t诱导以肿瘤内内源性和过继转移T细胞浸润为特征的局部免疫。
  • CAR T细胞介导的肿瘤杀伤诱导病毒从死亡肿瘤细胞释放,促进肿瘤CD19t表达传播。

临床怎么用

  • 该策略利用溶瘤病毒在肿瘤局部递送CAR靶点,为缺乏肿瘤限制性和均一表达抗原的实体瘤提供联合免疫治疗思路。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chimeric antigen receptor (CAR)-engineered T cell therapy for solid tumors is limited by the lack of both tumor-restricted and homogeneously expressed tumor antigens. Therefore, we engineered an oncolytic virus to express a nonsignaling, truncated CD19 (CD19t) protein for tumor-selective delivery, enabling targeting by CD19-CAR T cells. Infecting tumor cells with an oncolytic vaccinia virus coding for CD19t (OV19t) produced de novo CD19 at the cell surface before virus-mediated tumor lysis. Cocultured CD19-CAR T cells secreted cytokines and exhibited potent cytolytic activity against infected tumors. Using several mouse tumor models, delivery of OV19t promoted tumor control after CD19-CAR T cell administration. OV19t induced local immunity characterized by tumor infiltration of endogenous and adoptively transferred T cells. CAR T cell-mediated tumor killing also induced release of virus from dying tumor cells, which propagated tumor expression of CD19t. Our study features a combination immunotherapy approach using oncolytic viruses to promote de novo CAR T cell targeting of solid tumors.

来源:Sci Transl Med,查看原文。版权归原作者所有。

引用

  1. Park AK, Fong Y, Kim SI, et al. Effective combination immunotherapy using oncolytic viruses to deliver CAR targets to solid tumors. Sci Transl Med. 2020. PMID: 32878978. doi:10.1126/scitranslmed.aaz1863

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。